IN8bio, Inc. (INAB)
1.09
-0.05
(-4.39%)
USD |
NASDAQ |
Sep 09, 12:39
IN8bio Price : 1.09 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.20 | 1.20 | 1.13 | 1.14 | 31417.00 |
| Sep 04, 2026 | 1.16 | 1.22 | 1.16 | 1.20 | 22389.00 |
| Sep 03, 2026 | 1.10 | 1.16 | 1.096 | 1.16 | 41541.00 |
| Sep 02, 2026 | 1.09 | 1.11 | 1.085 | 1.10 | 6735.00 |
| Sep 01, 2026 | 1.10 | 1.13 | 1.08 | 1.09 | 19948.00 |
| Aug 31, 2026 | 1.01 | 1.13 | 1.01 | 1.10 | 36919.00 |
| Aug 28, 2026 | 1.04 | 1.05 | 1.03 | 1.035 | 24328.00 |
| Aug 27, 2026 | 1.19 | 1.19 | 0.96 | 1.04 | 130382.0 |
| Aug 26, 2026 | 1.17 | 1.20 | 1.165 | 1.185 | 3351.00 |
| Aug 25, 2026 | 1.18 | 1.200 | 1.11 | 1.17 | 58728.00 |
| Aug 24, 2026 | 1.30 | 1.30 | 1.145 | 1.18 | 72786.00 |
| Aug 21, 2026 | 1.23 | 1.30 | 1.18 | 1.28 | 105891.0 |
| Aug 20, 2026 | 1.22 | 1.255 | 1.17 | 1.21 | 17247.00 |
| Aug 19, 2026 | 1.16 | 1.26 | 1.155 | 1.20 | 79095.00 |
| Aug 18, 2026 | 1.135 | 1.17 | 1.13 | 1.14 | 45279.00 |
| Aug 17, 2026 | 1.11 | 1.14 | 1.052 | 1.11 | 36962.00 |
| Aug 14, 2026 | 1.19 | 1.200 | 1.10 | 1.10 | 56009.00 |
| Aug 13, 2026 | 0.9994 | 1.19 | 0.94 | 1.18 | 375670.0 |
| Aug 12, 2026 | 1.07 | 1.075 | 0.88 | 0.9985 | 90564.00 |
| Aug 11, 2026 | 1.00 | 1.05 | 0.9802 | 1.05 | 57920.00 |
| Aug 10, 2026 | 0.98 | 1.010 | 0.9579 | 0.9759 | 67434.00 |
| Aug 07, 2026 | 0.97 | 0.98 | 0.9507 | 0.9786 | 36583.00 |
| Aug 06, 2026 | 0.9888 | 0.9888 | 0.90 | 0.9699 | 76865.00 |
| Aug 05, 2026 | 1.00 | 1.000 | 0.94 | 0.9888 | 39883.00 |
| Aug 04, 2026 | 0.99 | 0.991 | 0.94 | 0.9601 | 37736.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 84.40 |
| Oncolytics Biotech, Inc. | 0.8084 |
| Sangamo Therapeutics, Inc. | 0.1609 |
| Sarepta Therapeutics, Inc. | 22.20 |
| Anixa Biosciences, Inc. | 2.82 |
Price Related Metrics
| Price to Book Value | 0.5849 |
| Earnings Yield | -170.9% |
| Market Cap | 10.74M |